ARCHIVES

ACS Challenged To Clarify Position On FDA Reform

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992

NCI Is Considering New Core Grants For Prostate, Breast Research Centers

April 19, 1991

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

New Office For Protection Of Research Subjects Formed.

June 23, 2000

Center Bitter Over NCI’s Reacting To IOM report, Core grant Losses, Program Staff Cuts

June 30, 1989

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

January 19, 1996